Target intelligence / Profile preview

MT-ND1 pseudogene 21 (MTND1P21)

Target
MTND1P21
Molecular classification
Other (Processed pseudogene)
01

Overview

MT-ND1 pseudogene 21 (MTND1P21) is classified as a processed pseudogene, meaning it is a DNA sequence similar to the mitochondrial NADH dehydrogenase 1 gene (MT-ND1) but has lost its protein-coding capacity due to mutations or truncations. It is located on chromosome 10 and is not known to be expressed as a functional protein or involved in mitochondrial electron transport. As a pseudogene, it is not considered a therapeutic target, enzyme, receptor, transporter, or involved in any known biological functions or disease processes. There is no published evidence linking it to drug interactions, biomarker status, or safety concerns [4][6][11]. Key points: MTND1P21 is not a protein-coding gene and has no known biological activity [4][6][11]. It is structurally related to the MT-ND1 gene, which encodes an essential mitochondrial protein, but MTND1P21 itself is non-functional [4][11]. It is not recognized as a therapeutic, diagnostic, or research target [4][6][11]. If you require information on the functional mitochondrial gene MT-ND1 (not the pseudogene), that gene is well characterized as part of mitochondrial respiratory Complex I and is linked to energy metabolism and several diseases [1][3][7][9][10]. MTND1P21, by contrast, does not share those functions.

Other names
MT-ND1 Pseudogene 21MTND1P21

Beyond the preview

Go deeper on MT-ND1 pseudogene 21 (MTND1P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND1 pseudogene 21 (MTND1P21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call